INICIO

Continuation of the Revista Mexicana de Cardiología

    
  • Home
  • Instructions for authors
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

The mexican health-care system and high blood pressure

Borrayo-Sánchez, Gabriela

ABSTRACT

High blood pressure (HBP) is the most prevalent risk factor in the Mexican population. The Mexican Social Security Institute (IMSS) has more than 69 million recorded affiliated populations. HBP is the second most important disease that financially impacts the IMSS. It has been estimated that the cost to treat HBP is 52,284 million Mexican pesos, which is only exceeded by diabetes and cancer. HBP represents a financial burden and reinforces the need to focus on promoting healthy lifestyles, prevention, timely detection, and treatment adherence. Some studies have shown costly-effective interventions, especially when standardization of treatment protocols, risk-based treatments, and task sharing with healthcare providers. The Comprehensive Care Protocol is one of the first strategies for health services in Mexico that includes evidence-based, multidisciplinary activities within all care settings, particularly the primary one for the treatment of HBP, which is discussed in length in this paper.
  FULL TEXT PDF  

Keywords

High blood pressure intervention healthcare systems




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • The detection and study of patient with high blood pressure
    2022, Vol.33, Núm. S3
  • Measurement of systemic arterial blood pressure
    2022, Vol.33, Núm. S3
  • Impact of alternative therapies in the treatment of resistant systemic arterial...
    2022, Vol.33, Núm. S3
  • Management of high blood pressure during all-trimesters of pregnancy
    2022, Vol.33, Núm. S3
  • High blood pressure and telemedicine: past, present and future
    2022, Vol.33, Núm. S3
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2


Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: EN TRÁMITE. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 4 de abril de 2022.

 

2022     |     https://www.cardiovascularandmetabolicscience.org.mx/